The Guideline Committee of the Japan
Introduction
The Guideline Committee of the Japan Lung Cancer Society (JLCS) for Thymic Tumors published the Medical Practice Guideline for Thymic Tumors in Japanese as Chapter 3 of the Medical Practice Guidelines for Lung Cancers according to evidence-based medicine in December 2016 (1) . This medical practice guideline is the first for thymic epithelial tumors in Japan and comprises a set of recommendations covering clinical diagnosis, treatment and pathological diagnosis.
Thymic epithelial tumors are a group of rare thoracic neoplasms including thymomas, thymic carcinomas and thymic neuroendocrine tumors, with a reported annual incidence of 1.3-3.2 per million. Therefore, a few guidelines have been proposed by the European Society Medical Oncology (2) and the National Comprehensive Cancer Network (3) .
In our guideline, since the data from large-scale analyses or clinical studies of thymic epithelial tumor are limited due to its low prevalence, the relevant recommendations and grading are based on available reported evidences and expert opinions as well as diagnostic methods and treatments commonly used in Japan. In this article, only topic-specific recommendations are addressed by the JLCS Medical Practice Guideline for Thymic Tumors based on tumor staging by the Masaoka's classification (4), in principle, as well as on histological classification according to the World Health Organization (WHO) criteria (5). Literature search was conducted over the period from 1 January 1980 to 31 October 2015 using PubMed.
Recommendation grades are defined as follows:
A: There is firm scientific evidence to strongly recommend the practice. • While the dose to normal tissues should be constrained in the same manner as for lung cancer, it is recommended to pay special attention to the cardiac dose, given that there are many young and/or long-term survivors. 7. Chemotherapy (Table 1) Pathological diagnosis comprises cytology, biopsy and the resected surgical specimen. Given few reports, the usefulness of cytological diagnosis is unclear.
(a) Processing of resected specimens: A resected tumor is recommended to be marked by the surgeon to indicate the anatomical relationship with surrounding tissues and organs, and to be extended on a board and then immediately fixed with sufficient fixative. It is recommended to make the largest cross-cut section of the tumor along horizontal CT plane, followed by additional parallel slices at intervals of 3-5 mm. 
Conclusion
Since there are few studies of thymic tumor with high level evidence due to relatively low prevalence, this guideline was prepared based on the opinions of a small number of experts, as well as diagnostic methods and treatments commonly used in Japan. Due to the scarcity, it may not be uncommon to have difficulty in diagnosing or treating thymic tumor in clinical practice. We sincerely hope that the guideline will be helpful in daily practice.
